Fondazione Giovanni Pascale
Also known as: Clinical Trials Unit, National Cancer Institute Naples | Experimental Pharmacology, National Cancer Institute Naples | Fondazione Giovanni Pascale | Hematology Oncology and Stem Cell Transplantation Unit , IRCCS Fondazione G.Pascale - Naples, Italy | IRCCS Fondazione G. Pascale, Naples | IRCCS I.N.T. "G. Pascale" | Istituto Nazionale dei Tumori - Fondazione G. Pascale | ISTITUTO NAZIONALE DEI TUMORI IRCCS - FONDAZIONE G. PASCALE NAPLES - ITALY | ISTITUTO NAZIONALE DEI TUMORI, NAPOLI | ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI FONDAZIONE GIOVANNI PASCALE DI NAPOLI | Istituto Nazionale per lo Studio e la Cura dei Tumori, Napoli | Istituto Nazionale Tumori Fondazione G. Pascale, 80131, Napoli, Italy | Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale - Napoli | Medical Oncology B, National Cancer Institute Naples | National Cancer Institute "Fondazione Pascale", Naples | National Cancer Institute, Naples | National Cancer Institute Naples (Italy) | National Cancer Institute Naples, Italy | National Cancer Institute, Naples Italy | National Cancer Institute Naples, Italy; Director Clinical Trials Unit | National Cancer Institute, Naples Italy; Director Clinical Trials Unit | National Cancer Institute, Naples, Italy; Director Clinical Trials Unit | National Cancer Institute (NCI), Naples | National Cancer Institute of Naples, Italy | National Tumor Institute, Naples, Italy | NCI Naples | NCI Naples, Clinical Trials Office | NCI Naples, Clinical Trials Unit | NCI Naples, Division of Medical Oncology C | NCI Naples, Division of Pain Therapy | NCI Naples, Division of Surgical Oncology A
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2000Last known activity
Dec 31, 2025
Timeline
1930s
- Jun 1, 1933
Fondazione Giovanni Pascale— Founded
Drugs by trial phase (77 distinct, 81 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (40 own, 0 via acquisition)
Phase 2 (29 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Colonic Neoplasms
- Colorectal Neoplasms
- Digestive System Neoplasms
- Endometrial Neoplasms
- Fallopian Tube Neoplasms
- Gastrointestinal Neoplasms
- Head and Neck Neoplasms
- Hodgkin Disease
- Hypersensitivity
- Intractable Pain
- Leukemia
- Leukemia, Lymphoid
- Lung Neoplasms
- Lymphoma
- Lymphoma, Non-Hodgkin
- Melanoma
- Mesothelioma
- Nausea
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Connective and Soft Tissue
- Neoplasms, Second Primary
- Neuralgia
- Neuroendocrine Tumors
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Pneumonia
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prostatic Neoplasms
- Rectal Neoplasms
- Recurrence
- Respiratory Tract Neoplasms
- Skin Neoplasms
- Small Cell Lung Carcinoma
- Soft Tissue Neoplasms
- Squamous Cell Carcinoma of Head and Neck
- Urogenital Neoplasms
- Uterine Cervical Neoplasms
- Vomiting
Recent trials (50)
- NCT07290894Lead sponsorPhase 2Dec 31, 2025
- NCT07302451Sponsor investigatorPhase 2Dec 1, 2025
- NCT07302451Lead sponsorPhase 2Dec 1, 2025
- NCT07213557Lead sponsorPhase 2Nov 30, 2025
- NCT07213570Lead sponsorPhase 2Oct 31, 2025
- NCT06880523CollaboratorPhase 2Oct 21, 2025
- NCT06714357Lead sponsorPhase 2Dec 20, 2024
- NCT06509126Lead sponsorPhase 3Jun 12, 2024
- NCT06259929OfficialPhase 2Apr 1, 2024
- NCT06341764Lead sponsorPhase 2Sep 1, 2023
- NCT06341764OfficialPhase 2Sep 1, 2023
- NCT05821556Lead sponsorPhase 2Jun 12, 2023
- NCT06218511Lead sponsorPhase 1Nov 22, 2022
- NCT06218511OfficialPhase 1Nov 22, 2022
- NCT05255471Lead sponsorPhase 3Jan 21, 2022
Details
- Founded
- Naples, IT Jun 1, 1933
- Last known activity
- Dec 31, 2025